Effects in rats of adolescent exposure to cannabis smoke or THC on emotional behavior and cognitive function in adulthood.
Adolescents
Adult
Anxiety
Behavior
Cannabis
Cognition
Depression
Rats
Sex differences
THC
Journal
Psychopharmacology
ISSN: 1432-2072
Titre abrégé: Psychopharmacology (Berl)
Pays: Germany
ID NLM: 7608025
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
26
02
2019
accepted:
22
04
2019
pubmed:
3
5
2019
medline:
4
12
2019
entrez:
3
5
2019
Statut:
ppublish
Résumé
Cannabis use is common among adolescents and some research suggests that adolescent cannabis use increases the risk for depression, anxiety, and cognitive impairments in adulthood. In human studies, however, confounds may affect the association between cannabis use and the development of brain disorders. These experiments investigated the effects of adolescent exposure to either cannabis smoke or THC on anxiety- and depressive-like behavior and cognitive performance in adulthood in Long-Evans rats. Adolescent rats of both sexes were exposed to either cannabis smoke from postnatal days (P) 29-49 or ascending doses of THC from P35-45. When the rats reached adulthood (P70), anxiety-like behavior was investigated in the large open field and elevated plus maze, depressive-like behavior in the sucrose preference and forced swim tests, and cognitive function in the novel object recognition test. Despite sex differences on some measures in the open field, elevated plus maze, forced swim, and novel object recognition tests, there were no effects of either adolescent cannabis smoke or THC exposure, and only relatively subtle interactions between exposure conditions and sex, such that sex differences on some performance measures were slightly attenuated. Neither cannabis smoke nor THC exposure during adolescence produced robust alterations in adult behavior after a period of abstinence, suggesting that adverse effects associated with adolescent cannabis use might be due to non-cannabinoid concomitants of cannabis use.
Identifiants
pubmed: 31044291
doi: 10.1007/s00213-019-05255-7
pii: 10.1007/s00213-019-05255-7
pmc: PMC6752736
mid: NIHMS1528357
doi:
Substances chimiques
Dronabinol
7J8897W37S
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2773-2784Subventions
Organisme : NIDA NIH HHS
ID : R21 DA039349
Pays : United States
Organisme : NIDA NIH HHS
ID : DA039349
Pays : United States
Références
Eur J Pharmacol. 2000 Aug 18;402(1-2):87-93
pubmed: 10940361
Br J Psychiatry. 2002 Mar;180:216-21
pubmed: 11872513
Horm Behav. 2002 May;41(3):306-15
pubmed: 11971664
Behav Brain Res. 2002 Nov 15;136(2):583-92
pubmed: 12429420
BMJ. 2002 Nov 23;325(7374):1195-8
pubmed: 12446533
Eur J Pharmacol. 2003 Feb 28;463(1-3):3-33
pubmed: 12600700
Neurosci Biobehav Rev. 2003 Jan-Mar;27(1-2):163-78
pubmed: 12732232
Neuropsychopharmacology. 2003 Oct;28(10):1760-9
pubmed: 12888772
Pharmacol Biochem Behav. 2004 Aug;78(4):675-81
pubmed: 15301921
J Psychopharmacol. 2004 Dec;18(4):502-8
pubmed: 15582916
Eur J Pharmacol. 2004 Dec 3;506(1):63-9
pubmed: 15588625
Pharmacol Biochem Behav. 2006 Mar;83(3):448-55
pubmed: 16631921
Neuropharmacology. 2007 Feb;52(2):646-54
pubmed: 17098261
Nat Protoc. 2006;1(3):1306-11
pubmed: 17406415
Horm Behav. 2007 Sep;52(3):307-16
pubmed: 17568585
Neuropsychopharmacology. 2008 Apr;33(5):1113-26
pubmed: 17581536
Lancet. 2007 Jul 28;370(9584):319-28
pubmed: 17662880
Chem Biodivers. 2007 Aug;4(8):1770-804
pubmed: 17712819
Physiol Behav. 1991 Sep;50(3):511-7
pubmed: 1801003
Chem Res Toxicol. 2008 Feb;21(2):494-502
pubmed: 18062674
Neuropsychopharmacology. 2008 Oct;33(11):2760-71
pubmed: 18172430
Psychopharmacology (Berl). 2009 Apr;203(3):629-40
pubmed: 19048233
Hippocampus. 2009 Aug;19(8):763-72
pubmed: 19156848
Neurotox Res. 2009 May;15(4):291-302
pubmed: 19384563
Physiol Behav. 1991 Jan;49(1):69-72
pubmed: 2017482
Physiol Behav. 1991 Feb;49(2):245-50
pubmed: 2062894
Neuropharmacology. 2011 Feb-Mar;60(2-3):235-43
pubmed: 20850463
Nat Protoc. 2012 May 03;7(6):1009-14
pubmed: 22555240
PLoS One. 2012;7(5):e37313
pubmed: 22615973
Drug Alcohol Depend. 2012 Dec 1;126(3):369-78
pubmed: 22749560
Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):E2657-64
pubmed: 22927402
Methods Mol Biol. 2012;929:377-89
pubmed: 23007438
Front Psychiatry. 2013 Oct 16;4:130
pubmed: 24137134
Curr Psychiatry Rep. 2013 Dec;15(12):419
pubmed: 24234874
Front Psychiatry. 2014 Jun 13;5:67
pubmed: 24982640
Behav Brain Res. 2015 May 15;285:105-17
pubmed: 25169255
Biol Pharm Bull. 2014;37(9):1435-8
pubmed: 25177025
Neurobiol Dis. 2015 Jan;73:60-9
pubmed: 25281318
Clin Pharmacokinet. 2015 Feb;54(2):209-19
pubmed: 25316574
J Affect Disord. 2015 Feb 1;172:211-8
pubmed: 25451420
Physiol Behav. 1989 Aug;46(2):229-37
pubmed: 2602464
J Pharm Biomed Anal. 2015 Oct 10;114:145-51
pubmed: 26048666
Lancet Psychiatry. 2015 Jul;2(7):601-8
pubmed: 26303557
J Anal Toxicol. 2015 Oct;39(8):580-7
pubmed: 26378131
Psychoneuroendocrinology. 2015 Dec;62:389-91
pubmed: 26386543
Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):E500-8
pubmed: 26787878
Nat Rev Neurosci. 2016 May;17(5):293-306
pubmed: 27052382
PLoS One. 2016 Apr 11;11(4):e0153327
pubmed: 27065006
Eur Neuropsychopharmacol. 2016 Sep;26(9):1378-1389
pubmed: 27461514
Neuropharmacology. 2016 Nov;110(Pt A):419-430
pubmed: 27477533
MMWR Surveill Summ. 2016 Sep 02;65(11):1-28
pubmed: 27584586
Curr Atheroscler Rep. 2017 Jun;19(6):26
pubmed: 28432636
Exp Clin Psychopharmacol. 2017 Aug;25(4):242-248
pubmed: 28682102
Addiction. 2018 Feb;113(2):257-265
pubmed: 28734078
Biol Psychiatry. 2018 Oct 15;84(8):601-610
pubmed: 29861097
J Pharm Biomed Anal. 2018 Oct 25;160:119-125
pubmed: 30077950
Drug Alcohol Depend. 2018 Nov 1;192:16-28
pubmed: 30195242
Neurobiol Learn Mem. 2019 Jan;157:151-162
pubmed: 30521850
Psychopharmacology (Berl). 1987;93(3):358-64
pubmed: 3124165
Behav Brain Res. 1987 Aug;25(2):101-7
pubmed: 3675823
Physiol Behav. 1986;37(2):313-5
pubmed: 3737744
Science. 1972 Feb 25;175(4024):911-2
pubmed: 5008609
Arch Int Pharmacodyn Ther. 1984 May;269(1):12-9
pubmed: 6087750
Pharmacol Biochem Behav. 1981 Oct;15(4):577-82
pubmed: 6117083
Dev Psychobiol. 1980 Mar;13(2):107-10
pubmed: 7358217
Behav Neurosci. 1995 Feb;109(1):71-8
pubmed: 7734082
Psychopharmacology (Berl). 1995 Sep;121(1):66-72
pubmed: 8539342
Life Sci. 1996;58(25):PL365-72
pubmed: 8649214
Psychoneuroendocrinology. 1995;20(8):879-90
pubmed: 8834094
Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1476-81
pubmed: 9037078
Chemosphere. 1997 Feb;34(4):835-48
pubmed: 9569946
Behav Brain Res. 1998 Aug;94(2):301-10
pubmed: 9722280